Clinical trial
A Pilot Study of Neurocysticercosis Treatment
NCT00283699 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00283699 |
|---|---|
| Title | A Pilot Study of Neurocysticercosis Treatment |
| Official title | A Pilot Study of Neurocysticercosis Treatment |
| Lead sponsor | Columbia University, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neurocysticercosis |
| Intervention type | Drug, Other |
| Interventions | albendazole, placebo |
| Enrollment | 178 |
| Start date | Feb 1, 2001 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Jan 30, 2006 |
| Last update posted | Feb 8, 2010 |
| Countries | Ecuador |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: